Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thromb…
Medical - Devices
US, Alameda [HQ]
Ratios
12 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||
| Gross Margin | 66.94 | 65.14 | 66.00 | 66.66 | 64.88 | 65.06 | 65.75 | 67.95 | 60.34 | 63.59 | 63.18 | 64.49 | |
| Profit Margin | 2.68 | 4.61 | 1.79 | 1.27 | 5.63 | 1.40 | 1.48 | 8.85 | -3.44 | 0.35 | -0.24 | 8.59 | |
| Operating Margin | 4.69 | -1.27 | 2.40 | 2.25 | -0.51 | 0.35 | -0.19 | 8.68 | -6.95 | -1.00 | -2.15 | 6.95 | |
|
EPS Growth
|
- - | -54.69 | -193.92 | 364.71 | 444.44 | -71.43 | 28.57 | 672.22 | -138.85 | 113.20 | -174.19 | 4,580.15 | |
| EPS USD | 7.99 | 3.62 | -3.40 | 9.00 | 49.00 | 14.00 | 18.00 | 139.00 | -54.00 | 7.13 | -5.29 | 237.00 | |
| Return on Assets (ROA) | - - | 5.76 | 1.85 | 0.90 | 4.81 | 0.98 | 1.28 | 7.28 | -2.34 | 0.21 | -0.15 | 5.84 | |
| Return on Equity (ROE) | - - | -50.84 | -18.15 | 1.02 | 5.56 | 1.16 | 1.56 | 9.97 | -3.00 | 0.27 | -0.20 | 7.71 | |
| Return on Invested Capital (ROIC) | - - | -178.35 | -17.40 | 1.06 | 8.63 | 0.72 | -0.75 | 7.84 | -2.74 | 0.17 | 0.76 | 5.94 | |
| Solvency | |||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 8.43 | - - | - - | - - | - - | - - | 12.36 | 9.39 | 13.95 | 17.20 | 15.06 | |
| Debt/Equity | - - | -74.42 | - - | - - | - - | - - | - - | 16.94 | 12.05 | 18.19 | 23.60 | 19.88 | |
| Debt/EBITDA | - - | -416.26 | -87.50 | -467.74 | 980.44 | -4,346.52 | -111.56 | 20.04 | -19.53 | -1,522.05 | 2,727.97 | 52.70 | |
|
Debt/Capitalization
|
- - | -290.98 | - - | - - | - - | - - | - - | 14.48 | 10.75 | 15.39 | 19.10 | 16.58 | |
| Long-Term Debt/Capitalization | - - | -290.98 | - - | - - | - - | - - | - - | 13.22 | 10.00 | 14.64 | 18.31 | 15.78 | |
| Interest Debt per Share USD | - - | 0.24 | - - | 0.05 | - - | - - | - - | 2.37 | 2.16 | 4.77 | 6.23 | 6.15 | |
| Debt Growth | - - | - - | -100.00 | - - | - - | - - | - - | - - | -6.10 | 124.58 | 35.86 | -0.61 | |
| Liquidity | |||||||||||||
| Current Ratio | - - | 392.99 | 553.72 | 868.13 | 736.95 | 741.02 | 621.73 | 508.67 | 583.11 | 553.16 | 521.42 | 605.65 | |
| Quick Ratio | - - | 169.40 | 346.29 | 633.25 | 480.69 | 528.48 | 428.06 | 324.32 | 358.19 | 315.60 | 270.07 | 324.83 | |
| Cash Ratio | - - | 26.08 | 15.80 | 69.44 | 36.97 | 98.17 | 102.71 | 79.93 | 65.77 | 48.20 | 48.20 | 110.81 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | |||||||||||||
| Inventory Turnover | - - | 114.43 | 127.55 | 109.30 | 126.68 | 122.89 | 131.68 | 114.67 | 101.23 | 103.30 | 93.39 | 96.87 | |
| Receivables Turnover | - - | 675.55 | 610.28 | 632.03 | 607.63 | 575.39 | 543.30 | 516.90 | 488.98 | 558.15 | 416.52 | 524.62 | |
| Payables Turnover | - - | 2,360.67 | 1,817.21 | 2,416.71 | 2,250.32 | 1,725.94 | 1,864.05 | 1,161.02 | 1,575.14 | 2,028.22 | 1,169.18 | 1,384.20 | |
|
Asset Turnover
|
- - | 124.88 | 103.40 | 70.53 | 85.42 | 70.02 | 86.39 | 82.21 | 68.10 | 60.08 | 61.79 | 68.02 | |
| Fixed Turnover | - - | 4,374.59 | 2,422.51 | 2,079.04 | 1,226.78 | 1,080.18 | 1,256.64 | 404.13 | 439.79 | 329.21 | 291.14 | 352.33 | |
| Coverage | |||||||||||||
| Interest Coverage | - - | - - | - - | 772.46 | - - | - - | - - | - - | - - | -388.05 | -13,313.14 | 4,229.50 | |
| Asset Coverage | - - | 900 | - - | - - | - - | - - | - - | 600 | 900 | 500 | 400 | 500 | |
| Cash Flow Coverage (CFGR) | - - | -56.60 | - - | - - | - - | - - | - - | 32.39 | -43.02 | 5.48 | -23.61 | 41.53 | |
| EBITDA Coverage | - - | - - | - - | 700 | - - | - - | - - | - - | - - | -300 | 4,400 | 7,200 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | - - | 100 | 100 | - - | 100 | 100 | 100 | - - | - - | 100 | 100 | |
| Market Prospects | |||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | 0.19 | 0.41 | 0.22 | 0.37 | 0.76 | 0.15 | 0.15 | 0.85 | -0.31 | 0.03 | -0.02 | 0.94 | |
|
Price/Earnings (P/E)
|
51,700.48 | 24,696.16 | 45,091.11 | 27,288.22 | 13,120.29 | 66,635.94 | 66,805.17 | 11,780.30 | -32,503.54 | 402,711.24 | -420,494.67 | 10,620.13 | |
| Price/Earnings Growth (PEG) | - - | -451.54 | -232.52 | -74.82 | 29.52 | -932.90 | 2,338.18 | 17.52 | 234.09 | -3,557.40 | 2,413.95 | -2.32 | |
|
Price/Book (P/B)
|
- - | -12,556.38 | -8,183.47 | 277.55 | 729.19 | 775.02 | 1,044.38 | 1,174.85 | 975.72 | 1,107.33 | 842.79 | 819.33 | |
| Price/Tangible Book (P/TB) | - - | -12,556.38 | -8,183.47 | 277.55 | 729.19 | 775.02 | 1,044.38 | 1,174.85 | 975.72 | 1,107.33 | 842.79 | 819.33 | |
| Price/Sales (P/S) | 1,384.03 | 1,139.36 | 806.55 | 346.79 | 738.14 | 929.77 | 991.11 | 1,042.83 | 1,116.89 | 1,412.96 | 993.74 | 912.54 | |
|
Price/Cash Flow (P/CF)
|
- - | -29,808.46 | -15,844.35 | -2,896.75 | -15,176.39 | 24,452.26 | 15,307.59 | 21,418.65 | -18,829.21 | 111,167.29 | -15,124.24 | 9,924.11 | |
| Price/Free CF (P/FCF) | - - | -24,136.75 | -9,850.11 | -2,325.39 | -7,350.58 | -132,560.27 | 22,961.78 | 125,654.82 | -10,792.11 | -90,453.12 | -11,230.54 | 11,762.58 | |
| Price/Operating CF (P/OCF) | - - | -29,808.46 | -15,844.35 | -2,896.75 | -15,176.39 | 24,452.26 | 15,307.59 | 21,418.65 | -18,829.21 | 111,167.29 | -15,124.24 | 9,924.11 |